The chemical class known as LOC100040585 Inhibitors refers to a specific group of compounds designed to target and inhibit the activity of the gene product expressed by LOC100040585. This gene, identified through extensive genomic and molecular studies, is implicated in a range of cellular functions and processes. The role of LOC100040585 is highly context-dependent, varying according to the cellular environment and external factors. The inhibitors targeting this gene are developed with precision, focusing on selectively binding to the proteins or enzymes that result from the expression of LOC100040585. This selective binding is crucial as it directly influences the biochemical pathways in which the LOC100040585 gene product is involved. By modulating the activity of this gene product, these inhibitors aim to impact the associated cellular processes, playing a significant role in altering specific cellular functions.
The development of LOC100040585 Inhibitors is an interdisciplinary effort, combining insights from molecular biology, biochemistry, and pharmacology. The initial step in this process involves an in-depth understanding of the structure and function of the LOC100040585 gene product. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are extensively used to gain a detailed perspective of the target molecule. This comprehensive understanding enables the rational design of inhibitors that are effective and highly specific to their target. Typically, these inhibitors are small molecules, designed to efficiently penetrate cell membranes and engage in a stable and potent interaction with their target. The molecular design of these inhibitors is carefully optimized to ensure strong interactions with the target molecule, usually involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The efficacy of these inhibitors is rigorously tested through a series of biochemical assays. These assays are critical for evaluating the potency, specificity, and overall interaction profile of the inhibitors, providing insights into their behavior in controlled experimental conditions. Such studies are vital for understanding the inhibitors' mechanism of action and for laying the groundwork for further research into their interaction dynamics and impact on cellular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase, inhibiting RNA synthesis and thus gene expression in bacteria. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Adenosine analog that can terminate mRNA elongation, potentially reducing gene expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Blocks N-linked glycosylation, potentially leading to ER stress and reduced protein expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Alkylates DNA and forms crosslinks, potentially impeding transcription and reducing gene expression. | ||||||
Acridine Orange solution | 65-61-2 | sc-473594 | 10 ml | $166.00 | 2 | |
DNA intercalator that can disrupt DNA replication and transcription, affecting gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, which can reduce mRNA synthesis and gene expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, leading to DNA damage and potential suppression of gene expression. | ||||||
Actinonin | 13434-13-4 | sc-201289 sc-201289B | 5 mg 10 mg | $170.00 $385.00 | 3 | |
Peptide that inhibits aminopeptidase M, potentially affecting protein processing and gene expression. | ||||||
Hygromycin B solution | 31282-04-9 | sc-29067 | 1 g | $104.00 | 40 | |
Aminoglycoside compound that inhibits protein synthesis, potentially affecting gene expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerase alpha and delta, leading to inhibition of DNA synthesis and potential effects on gene expression. | ||||||